Cargando…
Cancer Immunotherapy and Identification of Prognostic and Predictive Biomarkers
Autores principales: | Criscitiello, Carmen, Santangelo, Michele, Loupakis, Fotios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5884437/ https://www.ncbi.nlm.nih.gov/pubmed/29750158 http://dx.doi.org/10.1155/2018/5184075 |
Ejemplares similares
-
Cancer care during the spread of coronavirus disease 2019 (COVID-19) in Italy: young oncologists’ perspective
por: Lambertini, Matteo, et al.
Publicado: (2020) -
Prognostic and Predictive Biomarkers in the Era of Immunotherapy for Lung Cancer
por: Pabst, Lucile, et al.
Publicado: (2023) -
Breast Cancer Genetics: Diagnostics and Treatment
por: Criscitiello, Carmen, et al.
Publicado: (2022) -
Diagnostic, Prognostic, and Predictive Biomarkers in Breast Cancer
por: Li, Chia-Jung, et al.
Publicado: (2020) -
CD66b as a prognostic and predictive biomarker in patients with non-small cell lung cancer treated with checkpoint blockade immunotherapy
por: Jain, Swati, et al.
Publicado: (2023)